Skip to main content
. 2022 Jul 23;14(15):3600. doi: 10.3390/cancers14153600
ADR Adriamycin
HDACs histone deacetylases
PRC2 polycomb repressive complex 2
HDAC2 histone deacetylase 2
HDAC7 histone deacetylase 7
HDAC3 histone deacetylase 3
EZH2 enhancer of zeste homologue 2
PDK1 pyruvate dehydrogenase kinase 1
DNMT1 DNA methyltransferase 1
EMT epithelial-mesenchymal transition
CARM1 coactivator associated arginine methyltransferase 1
GLUTs glucose transporters
HK hexokinase
PFK phosphofructokinase
PK pyruvate kinase
PKM2 pyruvate kinase M2 isoform
TCA tricarboxylic acid
DMEM Dulbecco’s modified Eagle’s medium
RFP red fluorescent protein
OS overall survival
MUT mutation
WT wild type
Co-IP Co-immunoprecipitation
IF immunofluorescence
MMP mitochondrial membrane potential
MOD mean optical density
IHC immunohistochemistry
PDH pyruvate dehydrogenase